Sage Rhino Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Sell |
11,632
-185
| -2% | -$12.8K | 0.17% | 103 |
|
|
2025
Q1 | $821K | Sell |
11,817
-274
| -2% | -$19K | 0.19% | 97 |
|
|
2024
Q4 | $1.04M | Sell |
12,091
-294
| -2% | -$25.3K | 0.23% | 85 |
|
|
2024
Q3 | $1.47M | Buy |
12,385
+55
| +0.4% | +$6.55K | 0.33% | 61 |
|
|
2024
Q2 | $1.76M | Buy |
12,330
+10
| +0.1% | +$1.43K | 0.42% | 54 |
|
|
2024
Q1 | $1.58M | Buy |
12,320
+89
| +0.7% | +$11.4K | 0.37% | 58 |
|
|
2023
Q4 | $1.27M | Buy |
12,231
+71
| +0.6% | +$7.35K | 0.32% | 62 |
|
|
2023
Q3 | $1.11M | Buy |
12,160
+160
| +1% | +$14.6K | 0.31% | 67 |
|
|
2023
Q2 | $971K | Sell |
12,000
-294
| -2% | -$23.8K | 0.27% | 74 |
|
|
2023
Q1 | $978K | Buy |
12,294
+204
| +2% | +$16.2K | 0.29% | 69 |
|
|
2022
Q4 | $818K | Buy |
12,090
+394
| +3% | +$26.7K | 0.26% | 75 |
|
|
2022
Q3 | $583K | Sell |
11,696
-294
| -2% | -$14.7K | 0.23% | 79 |
|
|
2022
Q2 | $668K | Buy |
11,990
+234
| +2% | +$13K | 0.26% | 73 |
|
|
2022
Q1 | $653K | Buy |
11,756
+512
| +5% | +$28.4K | 0.2% | 94 |
|
|
2021
Q4 | $630K | Buy |
11,244
+1,150
| +11% | +$64.4K | 0.18% | 102 |
|
|
2021
Q3 | $485K | Buy |
10,094
+312
| +3% | +$15K | 0.15% | 110 |
|
|
2021
Q2 | $410K | Buy |
9,782
+460
| +5% | +$19.3K | 0.12% | 130 |
|
|
2021
Q1 | $314K | Buy |
9,322
+444
| +5% | +$15K | 0.1% | 134 |
|
|
2020
Q4 | $310K | Buy |
8,878
+14
| +0.2% | +$489 | 0.12% | 124 |
|
|
2020
Q3 | $308K | Sell |
8,864
-12
| -0.1% | -$417 | 0.15% | 112 |
|
|
2020
Q2 | $291K | Buy |
8,876
+226
| +3% | +$7.41K | 0.15% | 114 |
|
|
2020
Q1 | $260K | Buy |
8,650
+770
| +10% | +$23.1K | 0.19% | 99 |
|
|
2019
Q4 | $231K | Buy |
7,880
+104
| +1% | +$3.05K | 0.13% | 131 |
|
|
2019
Q3 | $201K | Sell |
7,776
-120
| -2% | -$3.1K | 0.13% | 133 |
|
|
2019
Q2 | $202K | Buy |
+7,896
| New | +$202K | 0.13% | 124 |
|